VALN - U.S. recommends a pause in Valneva chikungunya vaccine for those over 60
2025-05-10 07:57:38 ET
More on Valneva
- Valneva SE (VALN) Q1 2025 Earnings Call Transcript
- Valneva SE 2025 Q1 - Results - Earnings Call Presentation
- Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance
- Valneva reports Q1 results
- Valneva dips as EU suspends use of chikungunya shot in older adults